The ISG15/ISGylation system can be oncogenic or have tumor suppressor activity depending on the tissue affected, cancer stage, and specific cancer-related alterations in signalling pathways (Han et al., 2018; Kang et al., 2022). The gene discussed is ISG15; the disease is neoplasm.